|Bid||552.77 x 900|
|Ask||575.15 x 1000|
|Day's Range||560.93 - 573.65|
|52 Week Range||305.63 - 579.00|
|Beta (5Y Monthly)||0.74|
|PE Ratio (TTM)||109.19|
|Earnings Date||Oct. 25, 2021 - Oct. 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||522.55|
DexCom (DXCM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DexCom's (DXCM) third-quarter results are likely to reflect rising global awareness of its real-time CGM.
If you invest for the long term, you don't need to worry about short-term fluctuations in the market or what retail investors are betting on today. Two stocks that fall into that category are DexCom (NASDAQ: DXCM) and Microsoft (NASDAQ: MSFT). Luckily, DexCom and its continuous glucose monitoring devices can help patients manage the issue.